Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI
  • Top
  • Footnotes
  • Version history

Advertisement

Corrigendum Free access | 10.1172/JCI128527

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer

Donghyun D. Lee, Ricardo Leão, Martin Komosa, Marco Gallo, Cindy H. Zhang, Tatiana Lipman, Marc Remke, Abolfazl Heidari, Nuno Miguel Nunes, Joana D. Apolónio, Aryeh J. Price, Ramon Andrade De Mello, João S. Dias, David Huntsman, Thomas Hermanns, Peter J. Wild, Robert Vanner, Gelareh Zadeh, Jason Karamchandani, Sunit Das, Michael D. Taylor, Cynthia E. Hawkins, Jonathan D. Wasserman, Arnaldo Figueiredo, Robert J. Hamilton, Mark D. Minden, Khalida Wani, Bill Diplas, Hai Yan, Kenneth Aldape, Mohammad R. Akbari, Arnavaz Danesh, Trevor J. Pugh, Peter B. Dirks, Pedro Castelo-Branco, and Uri Tabori

Find articles by Lee, D. in: JCI | PubMed | Google Scholar

Find articles by Leão, R. in: JCI | PubMed | Google Scholar

Find articles by Komosa, M. in: JCI | PubMed | Google Scholar

Find articles by Gallo, M. in: JCI | PubMed | Google Scholar

Find articles by Zhang, C. in: JCI | PubMed | Google Scholar

Find articles by Lipman, T. in: JCI | PubMed | Google Scholar

Find articles by Remke, M. in: JCI | PubMed | Google Scholar

Find articles by Heidari, A. in: JCI | PubMed | Google Scholar

Find articles by Nunes, N. in: JCI | PubMed | Google Scholar

Find articles by Apolónio, J. in: JCI | PubMed | Google Scholar

Find articles by Price, A. in: JCI | PubMed | Google Scholar

Find articles by De Mello, R. in: JCI | PubMed | Google Scholar

Find articles by Dias, J. in: JCI | PubMed | Google Scholar

Find articles by Huntsman, D. in: JCI | PubMed | Google Scholar

Find articles by Hermanns, T. in: JCI | PubMed | Google Scholar

Find articles by Wild, P. in: JCI | PubMed | Google Scholar

Find articles by Vanner, R. in: JCI | PubMed | Google Scholar

Find articles by Zadeh, G. in: JCI | PubMed | Google Scholar

Find articles by Karamchandani, J. in: JCI | PubMed | Google Scholar

Find articles by Das, S. in: JCI | PubMed | Google Scholar

Find articles by Taylor, M. in: JCI | PubMed | Google Scholar

Find articles by Hawkins, C. in: JCI | PubMed | Google Scholar

Find articles by Wasserman, J. in: JCI | PubMed | Google Scholar

Find articles by Figueiredo, A. in: JCI | PubMed | Google Scholar

Find articles by Hamilton, R. in: JCI | PubMed | Google Scholar

Find articles by Minden, M. in: JCI | PubMed | Google Scholar

Find articles by Wani, K. in: JCI | PubMed | Google Scholar

Find articles by Diplas, B. in: JCI | PubMed | Google Scholar

Find articles by Yan, H. in: JCI | PubMed | Google Scholar

Find articles by Aldape, K. in: JCI | PubMed | Google Scholar

Find articles by Akbari, M. in: JCI | PubMed | Google Scholar

Find articles by Danesh, A. in: JCI | PubMed | Google Scholar

Find articles by Pugh, T. in: JCI | PubMed | Google Scholar

Find articles by Dirks, P. in: JCI | PubMed | Google Scholar

Find articles by Castelo-Branco, P. in: JCI | PubMed | Google Scholar

Find articles by Tabori, U. in: JCI | PubMed | Google Scholar

First published April 1, 2019 - More info

Published in Volume 129, Issue 4 on April 1, 2019
J Clin Invest. 2019;129(4):1801–1801. https://doi.org/10.1172/JCI128527.
© 2019 American Society for Clinical Investigation
First published April 1, 2019 - Version history

Related article:

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
Donghyun D. Lee, … , Pedro Castelo-Branco, Uri Tabori
Donghyun D. Lee, … , Pedro Castelo-Branco, Uri Tabori
Categories: Concise Communication Oncology

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer

  • Text
  • PDF
Abstract

Replicative immortality is a hallmark of cancer cells governed by telomere maintenance. Approximately 90% of human cancers maintain their telomeres by activating telomerase, driven by the transcriptional upregulation of telomerase reverse transcriptase (TERT). Although TERT promoter mutations (TPMs) are a major cancer-associated genetic mechanism of TERT upregulation, many cancers exhibit TERT upregulation without TPMs. In this study, we describe the TERT hypermethylated oncological region (THOR), a 433-bp genomic region encompassing 52 CpG sites located immediately upstream of the TERT core promoter, as a cancer-associated epigenetic mechanism of TERT upregulation. Unmethylated THOR repressed TERT promoter activity regardless of TPM status, and hypermethylation of THOR counteracted this repressive function. THOR methylation analysis in 1,352 human tumors revealed frequent (>45%) cancer-associated DNA hypermethylation in 9 of 11 (82%) tumor types screened. Additionally, THOR hypermethylation, either independently or along with TPMs, accounted for how approximately 90% of human cancers can aberrantly activate telomerase. Thus, we propose that THOR hypermethylation is a prevalent telomerase-activating mechanism in cancer that can act independently of or in conjunction with TPMs, further supporting the utility of THOR hypermethylation as a prognostic biomarker.

Authors

Donghyun D. Lee, Ricardo Leão, Martin Komosa, Marco Gallo, Cindy H. Zhang, Tatiana Lipman, Marc Remke, Abolfazl Heidari, Nuno Miguel Nunes, Joana D. Apolónio, Aryeh J. Price, Ramon Andrade De Mello, João S. Dias, David Huntsman, Thomas Hermanns, Peter J. Wild, Robert Vanner, Gelareh Zadeh, Jason Karamchandani, Sunit Das, Michael D. Taylor, Cynthia E. Hawkins, Jonathan D. Wasserman, Arnaldo Figueiredo, Robert J. Hamilton, Mark D. Minden, Khalida Wani, Bill Diplas, Hai Yan, Kenneth Aldape, Mohammad R. Akbari, Arnavaz Danesh, Trevor J. Pugh, Peter B. Dirks, Pedro Castelo-Branco, Uri Tabori

×

Original citation: J Clin Invest. 2019;129(1):223–229. https://doi.org/10.1172/JCI121303

Citation for this corrigendum: J Clin Invest. 2019;129(4):1801. https://doi.org/10.1172/JCI128527

Of the 1352 samples in the cohort, which were provided by multiple collaborators, four samples of breast tissue for which DNA was analyzed were a part of another study. Since these samples did not go through the same rigorous screening process, including pathology review and extraction of DNA from paraffin tissues, that was applied to all other samples, the authors are less confident in their exact identity and have decided to retract them from the study. This does not change the message of the paper, but results in changes in and in one pie chart in Figure 2E, that for breast cancer. The corrected figure parts are below. In addition, the supplemental material containing sample information has been updated online.

The authors regret the error.

Footnotes

See the related article at DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Version history
  • Version 1 (April 1, 2019): Print issue publication

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI

Go to:

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts